Table 5.
Univariate and multivariate logistic regression analysis on UI level for the presence of CLNM in PTC patients
| Urinary iodine status (μg/L) | Univariate | Multivariatec | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Total patientsa | ||||||
| ≤ 99 (n = 102) | 0.59 | 0.36–0.98 | 0.043 | 0.71 | 0.41–1.23 | 0.221 |
| 100–199 (n = 164) | Reference | Reference | ||||
| ≥ 200 (n = 93) | 0.98 | 0.59–1.63 | 0.934 | 0.99 | 0.59–1.83 | 0.98 |
| PTC ≥ 1 cma | ||||||
| ≤ 99 (n = 39) | 0.4 | 0.17–0.91 | 0.031 | 0.51 | 0.20–1.30 | 0.161 |
| 100–199 (n = 56) | Reference | Reference | ||||
| ≥ 200 (n = 30) | 1.03 | 0.41–2.69 | 0.956 | 1.26 | 0.44–3.73 | 0.674 |
| PTC < 1 cma | ||||||
| ≤ 99 (n = 63) | 0.7 | 0.36–1.33 | 0.281 | 0.73 | 0.35–1.48 | 0.381 |
| 100–199 (n = 108) | Reference | Reference | ||||
| ≥ 200 (n = 63) | 0.98 | 0.52–1.85 | 0.96 | 1.09 | 0.55–2.15 | 0.815 |
| Total patientsb | ||||||
| ≤ 109 (n = 135) | 0.44 | 0.26–0.72 | 0.001 | 0.53 | 0.31–0.91 | 0.021 |
| 110–189 (n = 120) | Reference | Reference | ||||
| ≥ 190 (n = 104) | 0.68 | 0.40–1.15 | 0.154 | 0.71 | 0.41–1.29 | 0.281 |
| PTC ≥ 1 cmb | ||||||
| ≤ 109 (n = 50) | 0.38 | 0.16–0.89 | 0.028 | 0.59 | 0.22–1.58 | 0.294 |
| 110–189 (n = 42) | Reference | Reference | ||||
| ≥ 190 (n = 33) | 0.9 | 0.34–2.40 | 0.826 | 1.33 | 0.45–4.06 | 0.608 |
| PTC < 1 cmb | ||||||
| ≤ 109 (n = 85) | 0.44 | 0.23–0.83 | 0.012 | 0.43 | 0.21–0.87 | 0.019 |
| 110–189 (n = 78) | Reference | Reference | ||||
| ≥ 190 (n = 71) | 0.61 | 0.32–1.18 | 0.143 | 0.65 | 0.32–1.33 | 0.242 |
aIodine insufficient, adequate, and above requirements (including excessive) were defined as ≤ 99 μg/L, 100–199 μg/L, and ≥ 200 μg/L
bIodine insufficient, adequate, and above requirements (including excessive) were defined as ≤ 109 μg/L, 110–189 μg/L, and ≥ 190 μg/L
cAdjusted for age, sex, multifocality, tumor size, and variant subtype